MedPath

Diabetes Prevention Program for Obese Latino Youth

Not Applicable
Completed
Conditions
Obesity
Insulin Resistance
Diabetes
Interventions
Other: Every Little Step Counts Intervention
Registration Number
NCT02039141
Lead Sponsor
Arizona State University
Brief Summary

The purpose of this study is to examine the effects of 12 week lifestyle intervention on diabetes risk in obese Latino adolescents.

Detailed Description

Obesity in the United States has reached epidemic proportions and Latinos youth are disproportionally impacted. Pediatric obesity is associated with several chronic health conditions including insulin resistance and type 2 diabetes. However, very few interventions specifically targeting diabetes prevention for obese Latino adolescents have been developed.

Therefore, the purpose of this study is to examine the effects a culturally-grounded, community-based lifestyle intervention on psychosocial and health outcomes among obese Latino adolescents. Eligible participants of this study will be randomly selected to the intervention group or the delayed-intervention group (control group) after an initial health screening for eligibility.

Participants selected to the intervention group will attend weekly healthy lifestyle education sessions with their parent(s)/guardian(s) and three physical activity sessions / week with other youth. After which, participants will attend monthly booster group meetings for three months.

All participants will be assessed at baseline, 3 months, 6 months, and 12 months for insulin sensitivity, glucose tolerance, quality of life, fitness, and nutrition and physical activity behaviors.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
160
Inclusion Criteria
  • Latino: self-report by parents
  • Age: 14-16
  • Obese: BMI percentile >= 95th percentile for age and gender or BMI >= 30 kg/m^2
Exclusion Criteria
  • Taking medication(s) or diagnosed with a condition that could influence carbohydrate metabolism, physical activity, and/or cognition
  • Type 2 diabetes: Fasting plasma glucose >= 126 mg/dL or 2-hour plasma glucose >= 200 mg/dL (youth found to be diabetic through study's procedures will be referred for follow up care and excluded)
  • Recent hospitalizations (previous 2 months)
  • Currently enrolled in (or with in previous 6 months) a formal weight loss program
  • Diagnosed depression or other condition that may impact QoL

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Every Little Step Counts InterventionEvery Little Step Counts InterventionExercise classes (3/week) Lifestyle sessions (1/week)
Primary Outcome Measures
NameTimeMethod
Change in Insulin Sensitivity / Glucose Tolerance, Measured at Baseline, Change 3-months, 6-months, and 12-monthsBaseline, 3 months after baseline, 6 months after baseline, 12 months after baseline

Proximal indicator of diabetes risk

Change in Quality of Life Measured at Baseline, 3-months, 6-months, and 12-monthsBaseline, 3 months after baseline, 6 months after baseline, 12 months after baseline

Generic and weight-specific quality of life

Secondary Outcome Measures
NameTimeMethod
Change in Self efficacy for healthy eating and exerciseBaseline, 3 months after baseline, 6 months after baseline, 12 months after baseline

These secondary outcomes measures aim to explore the mechanisms of the intervention by assessing the "mediated effect" on the outcomes of insulin sensitivity and weight-specific QoL through the following putative mediators targeted in the program: self-efficacy for healthy eating and exercise.

Change in Social support from family and friends on healthy eating and exercise.Baseline, 3 months after baseline, 6 months after baseline, 12 months after baseline

These secondary outcomes measures aim to explore the mechanisms of the intervention by assessing the "mediated effect" on the outcomes of insulin sensitivity and weight-specific QoL through the following putative mediators targeted in the program: Social support from family and friends on healthy eating and exercise.

Trial Locations

Locations (1)

Arizona State University

🇺🇸

Phoenix, Arizona, United States

© Copyright 2025. All Rights Reserved by MedPath